CLINICAL_TRIALS trial_result · 2022-10-06

Clinical Trial Update: Discontinuation of Disease Modifying Therapies (DMTs) in Multiple Sclerosis (MS) [Phase 4]

Phase 4 trial update on discontinuation of disease-modifying therapies (DMTs) in multiple sclerosis, with results posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: University of Colorado, Denver | Conditions: Multiple Sclerosis | Phase 4 | Status: COMPLETED | Results posted: 2022-10-06